Reference of 5-Bromo-2-chloropyridineIn 2013 ,《Discovery of SAR184841, a potent and long-lasting inhibitor of 11β-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D》 was published in Bioorganic & Medicinal Chemistry Letters. The article was written by Venier, Olivier; Pascal, Cecile; Braun, Alain; Namane, Claudie; Mougenot, Patrick; Crespin, Olivier; Pacquet, Francois; Mougenot, Cecile; Monseau, Catherine; Onofri, Benedicte; Dadji-Faihun, Rommel; Leger, Celine; Ben-Hassine, Majdi; Van-Pham, Thao; Ragot, Jean-Luc; Philippo, Christophe; Farjot, Geraldine; Noah, Lionel; Maniani, Karima; Boutarfa, Asma; Nicolai, Eric; Guillot, Etienne; Pruniaux, Marie-Pierre; Gussregen, Stefan; Engel, Christian; Coutant, Anne-Laure; de Miguel, Beatriz; Castro, Antonio. The article contains the following contents:
Starting from 11β-HSD1 inhibitors that were active ex vivo but with Cyp 3A4 liability, we obtained a new series of adamantane ureas displaying potent inhibition of both human and rodent 11β-HSD1 enzymes, devoid of Cyp 3A4 interactions, and rationally designed to provide long-lasting inhibition in target tissues. Final optimizations lead to SAR184841 with good oral pharmacokinetic properties showing in vivo activity and improvement of metabolic parameters in a physiopathol. model of type 2 diabetes. After reading the article, we found that the author used 5-Bromo-2-chloropyridine(cas: 53939-30-3Reference of 5-Bromo-2-chloropyridine)
5-Bromo-2-chloropyridine(cas: 53939-30-3) belongs to pyridine. Pyridine and pyridine-derived structures are privileged pharmacophores in medicinal chemistry and an essential functionality for organic chemists. As the prototypical π-deficient heterocycle, pyridine illustrates distinctive chemistry as both substrate and reagent. Reference of 5-Bromo-2-chloropyridine